Capsaicin-like effects of N-arachidonoyl-dopamine in the isolated guinea pig bronchi and urinary bladder

European Journal of Pharmacology

Volumn 475, Issue 1-3, 2003, Pages 107-114

  Harrison, Selena ^a   De Petrocellis, Luciano ^b   Trevisani, Marcello ^a   Benvenuti, Francesca ^a   Bifulco, Maurizio ^c   Geppetti, Pierangelo ^d   Di Marzo, Vincenzo ^e  

^a UNIVERSITY OF FERRARA   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF SALERNO   (Italy)

^d Dip Area Critica Med Chir   (Italy)

^e CNR   (Italy)

Author keywords

Anandamide; Cannabinoid; Cannabinoid CB1 receptor; Vanilloid; Vanilloid VR1 receptor

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N MORPHOLINO 1H PYRAZOLE 3 CARBOXAMIDE; ALCOHOL; ANANDAMIDE; CAPSAICIN; CAPSAZEPINE; CARBACHOL; DOPAMINE DERIVATIVE; FORSKOLIN; N ARACHIDONOYLDOPAMINE; N(G) NITROARGININE METHYL ESTER; NEUROKININ 1 RECEPTOR ANTAGONIST; NEUROKININ 2 RECEPTOR ANTAGONIST; NOLPITANTIUM; RECEPTOR BLOCKING AGENT; SAREDUTANT; UNCLASSIFIED DRUG; VANILLOID RECEPTOR;

ANIMAL TISSUE; ARTICLE; BLADDER; BLADDER CONTRACTION; BRONCHOSPASM; BRONCHUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; DRUG SCREENING; EPITHELIUM; GUINEA PIG; ISOLATED ORGAN; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION;

EID: 0042882846     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)02114-9     Document Type: Article

References (38)

1. Al-Hayani A., Wease K.N., Ross R.A., Pertwee R.G., Davies S.N. The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice. Neuropharmacology. 41:2001;1000-1005.
2. Andersson D.A., Adner M., Hogestatt E.D., Zygmunt P.M. Mechanisms underlying tissue selectivity of anandamide and other vanilloid receptor agonists. Mol. Pharmacol. 62:2002;705-713.
3. Bhave G., Zhu W., Wang H., Brasier D.J., Oxford G.S., Gereau R.W. IV cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation. Neuron. 35:2002;721-731.
4. Birder L.A., Nakamura Y., Kiss S., Nealen M.L., Barrick S., Kanai A.J., Wang E., Ruiz G., De Groat W.C., Apodaca G., Watkins S., Caterina M.J. Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nat. Neurosci. 5:2002;856-860.
5. Bisogno T., Melck D., Bobrov M.Yu., Gretskaya N.M., Bezuglov V.V., De Petrocellis L., Di Marzo V. N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo. Biochem. J. 351:2000;817-824.
6. Calignano A., Katona I., Desarnaud F., Giuffrida A., La Rana G., Mackie K., Freund T.F., Piomelli D. Bidirectional control of airway responsiveness by endogenous cannabinoids. Nature. 408:2000;96-101.
7. Carr M.J., Kollarik M., Meeker S.N., Undem B.J. A role for TRPV1 in bradykinin-induced excitation of vagal airway afferent nerve terminals. J. Pharmacol. Exp. Ther. 304:2003;1275-1279.
8. Caterina M.J., Leffler A., Malmberg A.B., Martin W.J., Trafton J., Petersen-Zeitz K.R., Koltzenburg M., Basbaum A.I., Julius D. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science. 288:2000;306-313.
9. Chan C.L., Facer P., Davis J.B., Smith G.D., Egerton J., Bountra C., Williams N.S., Anand P. Sensory fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and faecal urgency. Lancet. 361:2003;385-391.
10. Chu C.J., Huang S.M., De Petrocellis L., Bisogno T., Ewing S.A., Miller J.D., Zipkin R.E., Daddario N., Appendino G., Di Marzo V., Walker J.M. N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia. J. Biol. Chem. 278:2003;13633-13639.
11. Chung K.F., Chang A.B. Therapy for cough: active agents. Pulm. Pharmacol. Ther. 15:2002;335-338.
12. Cruz F. Vanilloid receptor and detrusor instability. Urology. 59(5 Suppl. 1):2002;51-60.
13. Davis J.B., Gray J., Gunthorpe M.J., Hatcher J.P., Davey P.T., Overend P., Harries M.H., Latcham J., Clapham C., Atkinson K., Hughes S.A., Rance K., Grau E., Harper A.J., Pugh P.L., Rogers D.C., Bingham S., Randall A., Sheardown S.A. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature. 405:2000;183-187.
14. De Petrocellis L., Bisogno T., Maccarrone M., Davis J.B., Finazzi-Agro A., Di Marzo V. The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. J. Biol. Chem. 276:2001;12856-12863.
15. De Petrocellis L., Harrison S., Bisogno T., Tognetto M., Brandi I., Smith G.D., Creminon C., Davis J.B., Geppetti P., Di Marzo V. The vanilloid receptor (VR1)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase. J. Neurochem. 77:2001;1660-1663.
16. Di Marzo V., Bisogno T., De Petrocellis L. Anandamide: some like it hot. Trends Pharmacol. Sci. 22:2001;346-349.
17. Di Marzo V., Lastres-Becker I., Bisogno T., De Petrocellis L., Milone A., Davis J.B., Fernandez-Ruiz J.J. Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues. Eur. J. Pharmacol. 420:2001;123-131.
18. Di Marzo V., De Petrocellis L., Fezza F., Ligresti A., Bisogno T. Anandamide receptors. Prostaglandins Leukot. Essent. Fat. Acids. 66:2002;377-391.
19. Doyle M.W., Bailey T.W., Jin Y.H., Andresen M.C. Vanilloid receptors presynaptically modulate cranial visceral afferent synaptic transmission in nucleus tractus solitarius. J. Neurosci. 22:2002;8222-8229.
20. Gunthorpe M.J., Benham C.D., Randall A., Davis J.B. The diversity in the vanilloid (TRPV) receptor family of ion channels. Trends Pharmacol. Sci. 23:2002;183-191.
21. Hillard C.J., Jarrahian A. The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes. Chem. Phys. Lipids. 108:2000;123-134.
22. Huang S.M., Bisogno T., Trevisani M., Al-Hayani A., De Petrocellis L., Fezza F., Tognetto M., Petros T.J., Krey J.F., Chu C.J., Miller J.D., Davies S.N., Geppetti P., Walker J.M., Di Marzo V. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc. Natl. Acad. Sci. U. S. A. 99:2002;8400-8405.
23. Hwang S.W., Cho H., Kwak J., Lee S.Y., Kang C.J., Jung J., Cho S., Min K.H., Suh Y.G., Kim D., Oh U. Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc. Natl. Acad. Sci. U. S. A. 97:2000;6155-6160.
24. Maccarrone M., Bari M., Lorenzon T., Bisogno T., Di Marzo V., Finazzi-Agro A. Anandamide uptake by human endothelial cells and its regulation by nitric oxide. J. Biol. Chem. 275:2000;13484-13492.
25. McVey D.C., Schmid P.C., Schmid H.H., Vigna S.R. Endocannabinoids induce ileitis in rats via the capsaicin receptor (VR1). J. Pharmacol. Exp. Ther. 304:2003;713-722.
26. Mezey E., Toth Z.E., Cortright D.N., Arzubi M.K., Krause J.E., Elde R., Guo A., Blumberg P.M., Szallasi A. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc. Natl. Acad. Sci. U. S. A. 97:2000;3655-3660.
27. Rathee P.K., Distler C., Obreja O., Neuhuber W., Wang G.K., Wang S.Y., Nau C., Kress M. PKA/AKAP/VR-1 module: a common link of Gs-mediated signaling to thermal hyperalgesia. J. Neurosci. 22:2002;4740-4745.
28. Sanchez J.F., Krause J.E., Cortright D.N. The distribution and regulation of vanilloid receptor VR1 and VR1 5′ splice variant RNA expression in rat. Neuroscience. 107:2001;373-381.
29. Savidge J., Davis C., Shah K., Colley S., Phillips E., Ranasinghe S., Winter J., Kotsonis P., Rang H., McIntyre P. Cloning and functional characterization of the guinea pig vanilloid receptor 1. Neuropharmacology. 43:2002;450-456.
30. Shin J., Cho H., Hwang S.W., Jung J., Shin C.Y., Lee S.Y., Kim S.H., Lee M.G., Choi Y.H., Kim J., Haber N.A., Reichling D.B., Khasar S., Levine J.D., Oh U. Bradykinin-12-lipoxygenase-VR1 signaling pathway for inflammatory hyperalgesia. Proc. Natl. Acad. Sci. U. S. A. 99:2002;10150-10155.
31. Smart D., Gunthorpe M.J., Jerman J.C., Nasir S., Gray J., Muir A.I., Chambers J.K., Randall A.D., Davis J.B. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br. J. Pharmacol. 129:2000;227-230.
32. Sterner O., Szallasi A. Novel natural vanilloid receptor agonists: new therapeutic targets for drug development. Trends Pharmacol. Sci. 20:1999;459-465.
33. Szallasi A. Vanilloid (capsaicin) receptors in health and disease. Am. J. Clin. Pathol. 118:2002;110-121.
34. Szallasi A., Blumberg P.M. Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol. Rev. 51:1999;159-212.
35. Szallasi A., Di Marzo V. New perspectives on enigmatic vanilloid receptors. Trends Neurosci. 23:2000;491-497.
36. Walker K.M., Urban L., Medhurst S.J., Patel S., Panesar M., Fox A.J., McIntyre P. The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain. J. Pharmacol. Exp. Ther. 304:2003;56-62.
37. Yiangou Y., Facer P., Dyer N.H., Chan C.L., Knowles C., Williams N.S., Anand P. Vanilloid receptor 1 immunoreactivity in inflamed human bowel. Lancet. 357:2001;1338-1339.
38. Zygmunt P.M., Petersson J., Andersson D.A., Chuang H., Sorgard M., Di Marzo V., Julius D., Hogestatt E.D. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature. 400:1999;452-457.